IA

Irshad Ahmed Razzack

Active Director Director DIN 08284065
DIN 08284065 First appointment Nov 2018 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2018
Shareholding value •••• Premium profile

About Irshad Ahmed Razzack

Data last updated:

Irshad Ahmed Razzack is a Director at Dermics Pharmaceuticals Private Limited (since 2018). The company operates in Trading. Dermics Pharmaceuticals Private Limited reported revenue of ₹7.3 Lakh (FY 2022).

DIN 08284065
Primary Designation Director
Industry Trading
First Appointment 21 Nov 2018
Oldest Company Age 7 yrs
Largest company Dermics Pharmaceuticals Private Limited · ₹7.3 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Nov 20182018₹7.3 Lakh (FY 2022)Active

Board colleagues of Irshad Ahmed Razzack

Directorship timeline

Open interactive timeline →
Dermics Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Irshad Ahmed Razzack

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Irshad Ahmed Razzack

Irshad Ahmed Razzack currently holds 1 directorship: Dermics Pharmaceuticals Private Limited (Director, since 21 Nov 2018, revenue ₹7.3 Lakh (FY 2022)).

Irshad Ahmed Razzack was first appointed on 21 Nov 2018 as Director at Dermics Pharmaceuticals Private Limited.

The current boards of Irshad Ahmed Razzack's companies include Chandrakumara Gumlapura Krishnappa (Dermics Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available